Walleye Trading LLC Novo Nordisk A S Call Options Transaction History

Walleye Trading LLC

$41.2 Billion
Q2 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $3.84 Million - $4.6 Million	-31,300 Reduced 59.06%	21,700 $3.1 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $1.08 Million - $1.44 Million	10,600 Added 25.0%	53,000 $6.81 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $2.12 Million - $2.54 Million	-24,100 Reduced 36.24%	42,400 $4.39 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $527,452 - $1.16 Million	5,800 Added 9.56%	66,500 $6.05 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $2.43 Million - $2.69 Million	-15,600 Reduced 20.45%	60,700 $9.82 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $2.25 Million - $2.71 Million	-17,000 Reduced 18.22%	76,300 $12.1 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $656,320 - $866,112	-6,400 Reduced 6.42%	93,300 $12.6 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $457,344 - $561,264	4,800 Added 5.06%	99,700 $9.93 Million
Q2 2022 Aug 08, 2022	BUY	$103.24 - $121.81 $9.45 Million - $11.1 Million	91,500 Added 2691.18%	94,900 $10.6 Million
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $2.11 Million - $2.55 Million	-22,700 Reduced 86.97%	3,400 $378,000
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $1.05 Million - $1.28 Million	10,900 Added 71.71%	26,100 $2.92 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $616,266 - $778,326	7,300 Added 92.41%	15,200 $1.46 Million
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $385,662 - $483,132	5,700 Added 259.09%	7,900 $662,000
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $2.79 Million - $3.15 Million	-41,600 Reduced 94.98%	2,200 $148,000
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $281,116 - $324,720	-4,400 Reduced 9.13%	43,800 $3.06 Million
Q3 2020 Nov 16, 2020	BUY	$63.69 - $70.22 $1.32 Million - $1.45 Million	20,700 Added 75.27%	48,200 $3.35 Million
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $333,678 - $387,258	5,700 Added 26.15%	27,500 $1.8 Million
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $153,326 - $200,818	-3,100 Reduced 12.45%	21,800 $1.31 Million
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $693,054 - $809,814	-13,900 Reduced 35.82%	24,900 $1.44 Million
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $1.74 Million - $1.96 Million	-36,700 Reduced 48.61%	38,800 $2.01 Million
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $991,948 - $1.11 Million	21,200 Added 39.04%	75,500 $3.85 Million
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $338,428 - $384,199	7,300 Added 15.53%	54,300 $2.84 Million
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $764,336 - $869,400	-18,400 Reduced 28.13%	47,000 $2.17 Million
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $2.6 Million - $2.85 Million	55,600 Added 567.35%	65,400 $3.08 Million
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $411,897 - $468,906	9,300 Added 1860.0%	9,800 $452,000
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $1.55 Million - $1.85 Million	-31,900 Reduced 98.46%	500 $25,000
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $4 Million - $4.52 Million	-84,100 Reduced 72.19%	32,400 $1.74 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $4.14 Million - $4.95 Million	100,500 Added 628.13%	116,500 $5.61 Million
Q2 2017 Aug 14, 2017	BUY	N/A	16,000	16,000 $688,000

Others Institutions Holding NVO

# of Institutions

1,991

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

Jennison Associates LLC

21.2M
Shares

$2.56 Billion
1.95% of portfolio
Morgan Stanley New York, NY

14.6M
Shares

$1.76 Billion
0.16% of portfolio
Bank Of America Corp Charlotte, NC

14.2M
Shares

$1.71 Billion
0.18% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.4M
Shares

$1.61 Billion
0.83% of portfolio
Fayez Sarofim & CO Houston, TX

12.6M
Shares

$1.52 Billion
4.91% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $273B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account